市场调查报告书
商品编码
1468362
治疗床市场报告(按产品(临床床、家用床、配件)、应用(急诊床、重症护理床、长期床)、最终用户(医院和诊所、生殖护理中心等)和地区 2024 -2032Therapeutic Beds Market Report by Product (Clinical Beds, Household Beds, Accessories), Application (Acute Care Beds, Critical Care Beds, Long-term Beds), End User (Hospital and Clinics, Reproductive Care Centers, and Others), and Region 2024-2032 |
IMARC Group年全球治疗床市场规模达45亿美元。
临床治疗床是专门设计的床,可提供最大程度的患者舒适度并改善医疗服务。这些床旨在用于受控的临床环境,例如疗养院、诊断实验室和门诊诊所。这些可调式床还包括额外的定位辅助工具,例如垫子、枕头和楔子。与普通床相比,这些床和床垫的设计目的是降低穴位、调节体温、预防褥疮和改善血液流动。除此之外,它们还配备了先进的功能,如电子升降、侧轨和轮子,从而为患者提供便携性和安全性。如果发生手术、受伤或退化性疾病,治疗床可以满足与医疗状况相关的舒适度和定位需求。
全球市场主要由医疗保健领域的持续技术进步所推动。这可以归因于主要参与者所进行的广泛的研发(R&D)活动,重点是推出创新产品变体。除此之外,消费者对健康和保健意识的大幅提高是市场成长的重要推动因素。容易患多种慢性疾病并需要更长住院时间的老年人口数量不断增加,进一步推动了市场的发展。与此一致的是,不断扩大的医疗支出以及公共和私人机构为改善整体医疗基础设施而提供的资金不断增加,也是其他主要的成长诱导因素。影响市场的其他一些因素包括术前和术后重症监护服务的需求不断增加、生活方式相关疾病的患病率上升、患者护理支出的增加以及为改善床位与患者比例而增加的投资。
The global therapeutic beds market size reached US$ 4.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.6 Billion by 2032, exhibiting a growth rate (CAGR) of 4.23% during 2024-2032.
Clinical therapeutic beds are specially designed beds that provide maximum patient comfort and improve healthcare delivery. These beds are intended to be used in controlled clinical environments, such as nursing homes, diagnostic laboratories, and outpatient clinics. Additional positioning aids, such as pads, pillows, and wedges, are also included with these adjustable beds. When compared to regular beds, these beds and mattresses are designed to lower acupoints, regulate body temperature, prevent bedsores, and improve blood flow. In addition to this, they are equipped with advanced features, such as electronic elevation, side rails, and wheels, thereby providing portability and safety for patients. In the event of surgery, injury, or degenerative disease, therapy beds fulfill the comfort and positioning needs associated with the medical condition.
The global market is majorly driven by continual technological advancements in the healthcare sector. This can be attributed to the extensive research and development (R&D) activities conducted by the key players focusing on introducing innovative product variants. In addition to this, a considerable rise in consumer awareness regarding health and wellness is acting as a significant growth-inducing factor for the market. The market is further propelled by the rising geriatric population susceptible to developing several chronic illnesses and requiring longer hospital stays. In line with this, the expanding medical expenditure and growing funding by public and private agencies to improve the overall healthcare infrastructure are acting as other major growth-inducing factors. Some of the other factors contributing to the market include the escalating demand for preoperative and postoperative critical care services, the rising prevalence of lifestyle-related diseases, growing expenditure on patient care, and increasing investments for improving the number of beds to patient ratio.
IMARC Group provides an analysis of the key trends in each sub-segment of the global therapeutic beds market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and end user.
Clinical Beds
Regular Beds
ICU Beds
Pediatric Beds
Birthing Beds
Bariatric Beds
Low Air Loss Beds
Others
Household Beds
Accessories
Acute Care Beds
Critical Care Beds
Long-term Beds
Hospital and Clinics
Reproductive Care Centers
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Amico Group of Companies, Arjo AB, Centrobed Ltd., GF Health Products Inc., HARD Manufacturing Company Inc., Hill-Rom Holdings Inc. (Baxter International Inc.), Invacare Corporation, Medical Depot Inc. (DBA Drive DeVilbiss Healthcare), Medline Industries LP and Stryker Corporation.